Adenosine diphosphate (ADP)-induced thromboxane A2 generation in human platelets requires coordinated signaling through integrin αIIBβ3 and ADP receptors

被引:132
作者
Jin, JG
Quinton, TM
Zhang, J
Rittenhouse, SE
Kunapuli, SP
机构
[1] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
[3] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA
[4] Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
关键词
D O I
10.1182/blood.V99.1.193
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adenosine diphosphate (ADP) is a platelet agonist that causes platelet shape change and aggregation as well as generation of thromboxane A(2), another platelet agonist, through its effects on P2Y1, P2Y12, and P2X1 receptors. it is now reported that both 2-propylthio-D-beta gamma -dichloromethylene adenosine T-triphosphate (AR-C67085), a P2Y12 receptor-selective antagonist, and adenosine-2'-phosphate-5'-phosphate (A2P5P), a P2Y1 receptor-selective antagonist, inhibited ADP-induced thromboxane A(2) generation in a concentration-dependent manner, indicating that coactivation of the P2Y12 and P2Y1 receptors is essential for this event. SC49992, a fibrinogen receptor antagonist, blocked ADP-induced platelet aggregation and thromboxane A(2) production in a concentration-dependent manner. Similarly, P2 receptor antagonists or SC49992 blocked ADP-Induced arachidonic acid liberation. Whereas SC49992 blocked arachidonic acid-induced platelet aggregation, it failed to inhibit thromboxane A(2) generation induced by arachidonic acid. Thus, ADP-induced arachidonic acid liberation, but not subsequent conversion to thromboxane A(2), requires outside-in signaling through the fibrinogen receptor. The Fab fragment of ligand-induced binding site-6 (LIBS6) antibody, which induces a fibrinogen-binding site on the integrin alpha (IIb)beta (3), caused both platelet aggregation and thromboxane A(2) generation. Inhibitors of phosphoinositide 3-kinase, Syk, Src kinases, or protein tyrosine phosphatases inhibited platelet aggregation but not thromboxane A(2) generation, indicating that these signaling molecules have no significant role in phospholipase A(2) activation. In the presence of P2 receptor antagonists A2P5P or AR-C67085, LIBS6 failed to generate thromboxane A(2), suggesting that inside-out signaling through ADP receptors is necessary for this event. It was concluded that both outside-in signaling from the fibrinogen receptor and inside-out signaling from the P2Y1 and P2Y12 receptors are necessary for phospholipase A(2) activation, resulting in arachidonic acid liberation and thromboxane A(2) generation.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 41 条
[1]   A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets [J].
Banfic, H ;
Tang, XW ;
Batty, IH ;
Downes, CP ;
Chen, CS ;
Rittenhouse, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :13-16
[2]   Biphasic activation of PKBα/Akt in platelets -: Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate [J].
Banfic, H ;
Downes, CP ;
Rittenhouse, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11630-11637
[3]   ACTIVATION OF PHOSPHOLIPASE-A AND PHOSPHOLIPASE-C IN HUMAN-PLATELETS EXPOSED TO EPINEPHRINE - ROLE OF GLYCOPROTEIN-IIB GLYCOPROTEINS-IIIA AND DUAL ROLE OF EPINEPHRINE [J].
BANGA, HS ;
SIMONS, ER ;
BRASS, LF ;
RITTENHOUSE, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) :9197-9201
[4]   Genetic and pharmacological analyses of involvement of Src-family, Syk and Btk tyrosine kinases in platelet shape change -: Src-kinases mediate integrin αIIbβ3 inside-out signaling during shape change [J].
Bauer, M ;
Maschberger, P ;
Quek, L ;
Briddon, SJ ;
Dash, D ;
Weiss, M ;
Watson, SP ;
Siess, W .
THROMBOSIS AND HAEMOSTASIS, 2001, 85 (02) :331-340
[5]   Agonist-activated alpha nu beta 3 on platelets and lymphocytes binds to the matrix protein osteopontin [J].
Bennett, JS ;
Chan, C ;
Vilaire, G ;
Mousa, SA ;
DeGrado, WF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8137-8140
[6]  
Boyer JL, 1996, MOL PHARMACOL, V50, P1323
[7]   LONG-TERM ASPIRIN IN THE PREVENTION OF CARDIOVASCULAR DISORDERS - RECENT DEVELOPMENTS AND VARIATIONS ON A THEME [J].
CATELLALAWSON, F ;
FITZGERALD, GA .
DRUG SAFETY, 1995, 13 (02) :69-75
[8]   INTERRELATIONS OF PLATELET-AGGREGATION AND SECRETION [J].
CHARO, IF ;
FEINMAN, RD ;
DETWILER, TC .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (04) :866-873
[9]   Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets [J].
Daniel, JL ;
Dangelmaier, C ;
Jin, JG ;
Ashby, B ;
Smith, JB ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2024-2029
[10]   P2Y1-receptors in human platelets which are pharmacologically distinct from P2YADP-receptors [J].
Fagura, MS ;
Dainty, IA ;
McKay, GD ;
Kirk, IP ;
Humphries, RG ;
Robertson, MJ ;
Dougall, IG ;
Leff, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :157-164